Trials / Unknown
UnknownNCT04199325
Probiotics for Gout / Hyperuricemia: A Randomized, Intervention, Parallel Controlled, Multicenter Clinical Trial
Probiotics for Gout / Hyperuricemia: A Randomized, Double-blind, Intervention, Parallel Controlled, Multicenter Clinical Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- The Affiliated Hospital of Inner Mongolia Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Under the premise of double-blind and non-interference clinical treatment, to evaluate the clinical efficacy and safety of probiotic Lactobacillus Zhang combined with routine treatment for gout hyperuricemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotics | Patients will be randomly assigned to the routine treatment + placebo group and probiotics + routine treatment group according to 1:2 ratio. |
| DRUG | uric-acid-lowering drug | Patients will be randomly assigned to the routine treatment + placebo group and probiotics + routine treatment group according to 1:2 ratio. |
Timeline
- Start date
- 2018-11-01
- Primary completion
- 2023-12-01
- Completion
- 2024-03-01
- First posted
- 2019-12-13
- Last updated
- 2023-07-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04199325. Inclusion in this directory is not an endorsement.